Cargando…

Dynamic Changes in the Endocannabinoid System during the Aging Process: Focus on the Middle-Age Crisis

Endocannabinoid (eCB) signaling is markedly decreased in the hippocampus (Hip) of aged mice, and the genetic deletion of the cannabinoid receptor type 1 (CB1) leads to an early onset of cognitive decline and age-related histological changes in the brain. Thus, it is hypothesized that cognitive aging...

Descripción completa

Detalles Bibliográficos
Autores principales: Nidadavolu, Prakash, Bilkei-Gorzo, Andras, Effah, Felix, Leidmaa, Este, Schürmann, Britta, Berger, Moritz, Bindila, Laura, Schmid, Matthias, Lutz, Beat, Zimmer, Andreas, Bailey, Alexis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499672/
https://www.ncbi.nlm.nih.gov/pubmed/36142165
http://dx.doi.org/10.3390/ijms231810254
_version_ 1784795049796567040
author Nidadavolu, Prakash
Bilkei-Gorzo, Andras
Effah, Felix
Leidmaa, Este
Schürmann, Britta
Berger, Moritz
Bindila, Laura
Schmid, Matthias
Lutz, Beat
Zimmer, Andreas
Bailey, Alexis
author_facet Nidadavolu, Prakash
Bilkei-Gorzo, Andras
Effah, Felix
Leidmaa, Este
Schürmann, Britta
Berger, Moritz
Bindila, Laura
Schmid, Matthias
Lutz, Beat
Zimmer, Andreas
Bailey, Alexis
author_sort Nidadavolu, Prakash
collection PubMed
description Endocannabinoid (eCB) signaling is markedly decreased in the hippocampus (Hip) of aged mice, and the genetic deletion of the cannabinoid receptor type 1 (CB1) leads to an early onset of cognitive decline and age-related histological changes in the brain. Thus, it is hypothesized that cognitive aging is modulated by eCB signaling through CB1. In the present study, we detailed the changes in the eCB system during the aging process using different complementary techniques in mouse brains of five different age groups, ranging from adolescence to old age. Our findings indicate that the eCB system is most strongly affected in middle-aged mice (between 9 and 12 months of age) in a brain region-specific manner. We show that 2-arachidonoylglycerol (2-AG) was prominently decreased in the Hip and moderately in caudate putamen (CPu), whereas anandamide (AEA) was decreased in both CPu and medial prefrontal cortex along with cingulate cortex (mPFC+Cg), starting from 6 months until 12 months. Consistent with the changes in 2-AG, the 2-AG synthesizing enzyme diacylglycerol lipase α (DAGLα) was also prominently decreased across the sub-regions of the Hip. Interestingly, we found a transient increase in CB1 immunoreactivity across the sub-regions of the Hip at 9 months, a plausible compensation for reduced 2-AG, which ultimately decreased strongly at 12 months. Furthermore, quantitative autoradiography of CB1 revealed that [(3)H]CP55940 binding markedly increased in the Hip at 9 months. However, unlike the protein levels, CB1 binding density did not drop strongly at 12 months and at old age. Furthermore, [(3)H]CP55940 binding was significantly increased in the lateral entorhinal cortex (LEnt), starting from the middle age until the old age. Altogether, our findings clearly indicate a middle-age crisis in the eCB system, which could be a potential time window for therapeutic interventions to abrogate the course of cognitive aging.
format Online
Article
Text
id pubmed-9499672
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94996722022-09-23 Dynamic Changes in the Endocannabinoid System during the Aging Process: Focus on the Middle-Age Crisis Nidadavolu, Prakash Bilkei-Gorzo, Andras Effah, Felix Leidmaa, Este Schürmann, Britta Berger, Moritz Bindila, Laura Schmid, Matthias Lutz, Beat Zimmer, Andreas Bailey, Alexis Int J Mol Sci Article Endocannabinoid (eCB) signaling is markedly decreased in the hippocampus (Hip) of aged mice, and the genetic deletion of the cannabinoid receptor type 1 (CB1) leads to an early onset of cognitive decline and age-related histological changes in the brain. Thus, it is hypothesized that cognitive aging is modulated by eCB signaling through CB1. In the present study, we detailed the changes in the eCB system during the aging process using different complementary techniques in mouse brains of five different age groups, ranging from adolescence to old age. Our findings indicate that the eCB system is most strongly affected in middle-aged mice (between 9 and 12 months of age) in a brain region-specific manner. We show that 2-arachidonoylglycerol (2-AG) was prominently decreased in the Hip and moderately in caudate putamen (CPu), whereas anandamide (AEA) was decreased in both CPu and medial prefrontal cortex along with cingulate cortex (mPFC+Cg), starting from 6 months until 12 months. Consistent with the changes in 2-AG, the 2-AG synthesizing enzyme diacylglycerol lipase α (DAGLα) was also prominently decreased across the sub-regions of the Hip. Interestingly, we found a transient increase in CB1 immunoreactivity across the sub-regions of the Hip at 9 months, a plausible compensation for reduced 2-AG, which ultimately decreased strongly at 12 months. Furthermore, quantitative autoradiography of CB1 revealed that [(3)H]CP55940 binding markedly increased in the Hip at 9 months. However, unlike the protein levels, CB1 binding density did not drop strongly at 12 months and at old age. Furthermore, [(3)H]CP55940 binding was significantly increased in the lateral entorhinal cortex (LEnt), starting from the middle age until the old age. Altogether, our findings clearly indicate a middle-age crisis in the eCB system, which could be a potential time window for therapeutic interventions to abrogate the course of cognitive aging. MDPI 2022-09-06 /pmc/articles/PMC9499672/ /pubmed/36142165 http://dx.doi.org/10.3390/ijms231810254 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Nidadavolu, Prakash
Bilkei-Gorzo, Andras
Effah, Felix
Leidmaa, Este
Schürmann, Britta
Berger, Moritz
Bindila, Laura
Schmid, Matthias
Lutz, Beat
Zimmer, Andreas
Bailey, Alexis
Dynamic Changes in the Endocannabinoid System during the Aging Process: Focus on the Middle-Age Crisis
title Dynamic Changes in the Endocannabinoid System during the Aging Process: Focus on the Middle-Age Crisis
title_full Dynamic Changes in the Endocannabinoid System during the Aging Process: Focus on the Middle-Age Crisis
title_fullStr Dynamic Changes in the Endocannabinoid System during the Aging Process: Focus on the Middle-Age Crisis
title_full_unstemmed Dynamic Changes in the Endocannabinoid System during the Aging Process: Focus on the Middle-Age Crisis
title_short Dynamic Changes in the Endocannabinoid System during the Aging Process: Focus on the Middle-Age Crisis
title_sort dynamic changes in the endocannabinoid system during the aging process: focus on the middle-age crisis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499672/
https://www.ncbi.nlm.nih.gov/pubmed/36142165
http://dx.doi.org/10.3390/ijms231810254
work_keys_str_mv AT nidadavoluprakash dynamicchangesintheendocannabinoidsystemduringtheagingprocessfocusonthemiddleagecrisis
AT bilkeigorzoandras dynamicchangesintheendocannabinoidsystemduringtheagingprocessfocusonthemiddleagecrisis
AT effahfelix dynamicchangesintheendocannabinoidsystemduringtheagingprocessfocusonthemiddleagecrisis
AT leidmaaeste dynamicchangesintheendocannabinoidsystemduringtheagingprocessfocusonthemiddleagecrisis
AT schurmannbritta dynamicchangesintheendocannabinoidsystemduringtheagingprocessfocusonthemiddleagecrisis
AT bergermoritz dynamicchangesintheendocannabinoidsystemduringtheagingprocessfocusonthemiddleagecrisis
AT bindilalaura dynamicchangesintheendocannabinoidsystemduringtheagingprocessfocusonthemiddleagecrisis
AT schmidmatthias dynamicchangesintheendocannabinoidsystemduringtheagingprocessfocusonthemiddleagecrisis
AT lutzbeat dynamicchangesintheendocannabinoidsystemduringtheagingprocessfocusonthemiddleagecrisis
AT zimmerandreas dynamicchangesintheendocannabinoidsystemduringtheagingprocessfocusonthemiddleagecrisis
AT baileyalexis dynamicchangesintheendocannabinoidsystemduringtheagingprocessfocusonthemiddleagecrisis